Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Finance

European office sales slumped to lowest since 2009 last year, data shows

Posted By Global Banking and Finance Review

Posted on January 30, 2025

European office sales slumped to lowest since 2009 last year, data shows

By Iain Withers

LONDON (Reuters) - Sales of office buildings in Europe last year slumped to their lowest level since the aftermath of the global financial crisis in 2009, even as the region's broader commercial property market showed signs of recovery, data showed on Thursday.

The commercial real estate market globally has endured tough trading since the COVID-19 pandemic, largely driven by higher borrowing costs and changing working patterns, the latter hitting offices particularly hard.

Last year 42.4 billion euros ($44.1 billion) worth of office properties changed hands in Europe, down 10% on the prior year and representing the lowest volume in 15 years, according to data from MSCI.

Sales of offices remain in the doldrums in Europe, with few larger deals and those put on the market - such as London's CityPoint and 'Can of Ham' towers - struggling to find buyers. Agents say only newer, greener offices remain in high demand.

However, after two years of contraction, deal volumes for Europe's wider commercial property sector turned positive in 2024 due to increased sales of industrial buildings, apartments and hotels, the MSCI data showed.

Across the overall sector, 188.8 billion euros worth of properties were sold, up 4% on the prior year, although this was still the second-lowest total in 12 years.

Tom Leahy, Head of EMEA Real Assets Research at MSCI, said real estate prices and Europe's broader growth prospects were still susceptible to ructions in bond markets, amid broader financial market volatility since Donald Trump began his second term as U.S. president.

"Certainly there are pockets of positive news which give grounds for optimism," Leahy said of the real estate market. "(However) the recovery is not happening everywhere and neither is it happening all at once."

Real estate investors in Europe rank residential, industrial and student accommodation as their top three investment preferences for this year, ahead of offices, a survey by trade body INREV published earlier this month found.

($1 = 0.9613 euros)

(Reporting by Iain Withers; Editing by Tommy Reggiori Wilkes, Kirsten Donovan)